Biotech Values

[dav1234]

I don't think anybody here likes ISRG except me..lol.

They obviously are a former market darling that have hit a few speed bumps lately on hysterectomy lawsuit issues and some bears complaining that davinci procedures do not offer a safety or cost benefit..

They are the leaders in the sector..I am no surgeon (or anything in medical field) but as a layman it would seem likely that robotic surgery will continue to grow ..there will be growing competition but I believe ISRG will continue to dominate..the key will be expanding the number of competently trained surgeons and that will increase procedures and demand for ISRG products..

The company has lots of cash..mgmt does reward themselves with obscene amounts of options ..their growth stopped acceleration last few quarters..most likely on all the press and bear hit pieces in the news..but I believe they will regain the growth as the negativity subsides..it will be volatile..I expect bear raid before earnings and will be waiting to add cheapies.